Cirrhosis Can Recur After Liver Transplant, Study Finds

A recent study published online on September 3 in the journal Portal Hypertension & Cirrhosis reports that cirrhosis can recur after liver transplantation. The research, which analyzed outcomes in a cohort of transplant recipients, found that a measurable proportion of patients experienced a return of liver scarring and associated portal hypertension within the first few years following surgery. The authors emphasize that recurrence is not inevitable but represents a significant complication that can impact graft survival and patient quality of life.

The investigators identified several factors that may predispose to recurrence, including underlying etiologies such as alcohol use disorder and non‑alcoholic steatohepatitis, as well as metabolic comorbidities like obesity and diabetes. They also noted that early post‑transplant surveillance—through imaging, liver function tests, and, when indicated, biopsy—can aid in the timely detection of cirrhosis re‑development. The study underscores the need for ongoing monitoring and tailored management strategies to mitigate the risk of graft failure.

These findings highlight that liver transplantation, while life‑saving, does not guarantee permanent resolution of cirrhosis. Clinicians and patients should remain vigilant for signs of recurrence and engage in comprehensive post‑transplant care to preserve graft function and improve long‑term outcomes.